WO2019132070A1 - Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics - Google Patents

Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics Download PDF

Info

Publication number
WO2019132070A1
WO2019132070A1 PCT/KR2017/015677 KR2017015677W WO2019132070A1 WO 2019132070 A1 WO2019132070 A1 WO 2019132070A1 KR 2017015677 W KR2017015677 W KR 2017015677W WO 2019132070 A1 WO2019132070 A1 WO 2019132070A1
Authority
WO
WIPO (PCT)
Prior art keywords
oleanolic acid
mixture
acid
weight
parts
Prior art date
Application number
PCT/KR2017/015677
Other languages
French (fr)
Korean (ko)
Inventor
정한수
조선행
안주영
이용우
Original Assignee
정한수
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 정한수 filed Critical 정한수
Publication of WO2019132070A1 publication Critical patent/WO2019132070A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Definitions

  • the present invention relates to a cosmetic for improving skin wrinkles. More specifically, the present invention relates to a cosmetic preparation for improving skin wrinkles, which comprises solubilizing and micellizing oleanolic acid as an insoluble polymer, This invention relates to an anti-aging cosmetic comprising nanoparticles useful for increasing solubility and improving skin permeability.
  • Skin aging occurs through two main processes.
  • the change that occurs with age without any special environmental factors is called intrinsic aging, and the change in appearance on the face, neck, and hands due to long exposure to environmental factors such as ultraviolet light It is called photo aging or extrinsic aging.
  • the main cause of the endogenous aging is the accumulation of damage to the constituents of the body due to reactive oxygen radicals produced in the metabolism of the body.
  • extrinsic aging is different in that harmful free radicals are produced by ultraviolet rays. Once active oxygen is produced, failure to effectively remove by various protective devices in the body results in a series of inflammatory reactions leading to skin damage, and typical damage to the skin is wrinkled skin.
  • retinol is widely known as a substance having a wrinkle-reducing effect in cosmetics, but it is vulnerable to heat or light, and it is photosensitive, so that a problem of making the skin more sensitive when exposed to sunlight is suggested.
  • oleanolic acid has been proposed as an alternative to retinol.
  • the oleanolic acid has poor solubility in a solvent such as water and solubilized in general cosmetics using water as a solvent There was a difficult problem,
  • Korean Patent Registration No. 10-1802963 relates to a cosmetic composition using a fermented extract, which comprises a fermented extract of a medicinal substance containing red ginseng and ginseng; Sustained fermentation extract; And a soybean fermentation extract.
  • a fermented extract which comprises a fermented extract of a medicinal substance containing red ginseng and ginseng; Sustained fermentation extract; And a soybean fermentation extract.
  • the cosmetic composition further comprises oleoanic acid as a skin pore filling agent.
  • the cosmetic composition according to the above-mentioned prior art can provide a skin-improving effect such as prevention of skin aging and alleviation of wrinkles by including a natural medicinal material, a fat and a fermented soybean extract as an active ingredient.
  • a natural medicinal material e.g., a hydroxybenzoic acid
  • a fat and a fermented soybean extract e.g., a hydroxybenzoic acid
  • the present invention relates to a cosmetic composition for improving the solubility of an insoluble oleanolic acid having the effect of improving skin wrinkles and containing nanoparticulate products containing micellized oleoanic acid Cosmetics, and the like.
  • the present invention has been made to solve the above-
  • the present invention relates to an anti-aging cosmetic composition
  • oleanolic acid and 1 to 30 parts by weight of a solubilizing agent are mixed with stirring to prepare a first mixture of oleanolic acid;
  • the cosmetic according to the present invention as described above can enhance the skin permeation effect of oleanolic acid having the effect of improving the wrinkles of the skin through the nanoparticulate product in which oleic acid is solubilized and micellized.
  • FIG. 1 shows the stability test results of nanoparticulate solubilizing insoluble oleoanic acid according to the first embodiment of the present invention.
  • FIG. 2 is an image showing a skin permeation test procedure of the nanoparticle useful solubilized with poorly soluble oleoanic acid according to the first embodiment of the present invention.
  • FIG. 3 is a graph showing the results of skin permeation test of nanoparticulate products solubilized with poorly soluble oleoanic acid according to the first embodiment of the present invention.
  • the nanoparticle-containing material has a particle size of 20 to 150 nm in order to improve permeability to the skin.
  • Oleanolic acid is known as a substance having an antioxidative effect.
  • it is a substance exhibiting an effect of improving skin wrinkles due to the constantly effective action.
  • Retinol which is known as a skin wrinkle-reducing substance, has a disadvantage in that it is unstable to heat or light and its effectiveness is reduced by half when it is contained as an effective substance in cosmetics.
  • oleanolic acid has been proposed as an alternative effective substance that can improve the disadvantages of retinol.
  • Oleanolic Acid is hardly soluble in water, which is a main component of cosmetics, and has a problem that it is difficult to permeate the skin because of its large particle size.
  • the present invention provides a method of preparing a solution of an oleanolic acid by mixing a solution aid and an amphiphilic polymer in the oleanolic acid so as to be able to react favorably in a soluble micelle form, Anionic acid was dissolved in distilled water to make cosmetics.
  • solubilizer serves as an adjuvant for both hydrophilic polymers which are dissolvers to micellize the oleoanic acid.
  • the dissolution aid may be any one or more of ethylene glycol, propylene glycol monocaprylate, tetraethylene glycol, polyethylene glycol, polypropylene glycol and polybutylene glycol, preferably ethylene glycol or propylene glycol And cocaprylate may be used.
  • the dissolution aid may be used in an amount of 1 to 30 parts by weight, preferably 2 to 10 parts by weight, based on 0.05 to 1 part by weight of the oleanolic acid. If the solubilizing agent is contained in an amount of less than 1 part by weight based on 1 part by weight of the oleanolic acid, the dispersion of the oleanolic acid is incomplete and the release of the oleoanic acid becomes difficult at the time of use of the cosmetic, When the amount is more than 30 parts by weight based on 1 part by weight, there is a problem that the stability of the oleanolic acid is insufficient and the reagent is wasted.
  • solubility of the oleanolic acid by the solubilizing aid it is possible to further use glycofurol, polysorbate, crmolpore, Solutol HS 15 and the like.
  • amphiphilic polymer plays a role of micelle formation and preferably triblock copolymers in the form of ⁇ polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)> More preferably, at least one of Poloxamer 184, Poloxamer 185, Poloxamer 188, Poloxamer 124, Poloxamer 237, Poloxamer 338 or Poloxamer 407 can be used.
  • PEO polyethylene oxide
  • PPO polypropylene oxide
  • PEO polyethylene oxide
  • Poloxamer 184 Poloxamer 185
  • Poloxamer 188 Poloxamer 124
  • Poloxamer 237 Poloxamer 338
  • Poloxamer 407 can be used.
  • the triblock copolymer is preferably contained in an amount of 1 to 30 parts by weight, more preferably 5 to 20 parts by weight, based on 0.01 to 1 part by weight of oleic acid. If the triblock copolymer is contained in an amount of less than 1 part by weight based on 0.01 to 1 part by weight of oleanolic acid, there is a problem that precipitation of oleanolic acid occurs, and when the amount of the triblock copolymer is 30 parts by weight per 1 part by weight of oleanolic acid There is a problem that the particle size is increased and the stability is lowered.
  • both of the above-mentioned biocompatible polymers have a high mixing ratio within the above-mentioned mixing ratio, so that the nanoparticle useful product is made into a gel-like form, and as the mixing ratio is lowered, the prepared nanoparticle-containing mule can be made into a liquid form.
  • the distilled water serves as a solvent for dissolving the oleanolic acid, the dissolution aid, and the biodegradable polymer.
  • the distilled water is preferably contained in an amount of 39 to 97.99 parts by weight based on 0.01 to 1 part by weight of oleic acid.
  • the distilled water contains less than 39 parts by weight of oleanolic acid based on 0.01 to 1 part by weight of the oleanolic acid, there is a problem that the oleanolic acid is not fully micellized.
  • 0.01 to 1 part by weight of oleanolic acid is used, There is a problem that the concentration of the produced nanoparticle useful substance may be excessively lowered.
  • the oleanolic acid, the solubilizing aid, the amphiphilic polymer, and the distilled water may be mixed together to form the nanoparticle useful product, but preferably the oleanolic acid and the dissolution aid
  • the oleanolic acid first mixture is added to the oleanolic acid first mixture and then the two ampholytic polymers are added to the oleanolic acid first mixture, and then the mixture is stirred under heating to prepare a second oleanolic acid mixture,
  • the second mixture of ricinic acid may be mixed with the distilled water to make the nanoparticle useful product.
  • the first oleanolic acid mixture is composed of an oleanolic acid and a solubilizing agent mixed with stirring, and the solubilizing agent is preferentially dispersed and mixed in oleic acid.
  • the dissolution aid when the dissolution aid is first dispersed in the oleanolic acid, the dissolution aid is first dissolved in the mixture of the oleanolic acid particles before the bilayer fibrillating polymer which mainly forms the micelle reacts with the oleinic acid, It is possible to obtain an effect of improving the micelle formation of oleanolic acid.
  • the oleanolic acid second mixture may be prepared by mixing the first oleanolic acid mixture with a biocompatible polymer.
  • the oleanolic acid contained in the first mixture of oleanolic acid may be heated to improve the reaction activity And is a constitution for increasing the solubilization of oleanolic acid having poor solubility.
  • the heating temperature for making the oleanolic acid second mixture is maintained at 30 to 80 ⁇ .
  • the heating temperature is less than 30 ° C, the reaction activity of oleanolic acid is somewhat insufficient, and if it exceeds 80 ° C, the oleanolic acid may be deteriorated.
  • the present invention relates to a method for producing an oleanolic acid, comprising: a first step of mixing 0.01 to 1 part by weight of oleanolic acid and 1 to 30 parts by weight of a solubilizing agent with stirring to prepare a first mixture of oleanolic acid; A second step of adding 1 to 30 parts by weight of an amphiphilic polymer to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture; A third step of adding 39 to 97.99 parts by weight of distilled water to the oleanolic acid second mixture, followed by stirring and mixing to form a nanoparticle useful product; And a fourth step of preparing a cosmetic product by mixing the nanoparticulate useful product with a carrier component contained in a known cosmetic product.
  • the method for manufacturing an anti-aging cosmetic product comprising the nanoparticulate product obtained by solubilizing the poorly soluble oleoanic acid .
  • the method of manufacturing a cosmetic product according to the present invention can produce a cosmetic product containing a nanoparticle useful product having a particle size of 20 to 150 nm in which the whitening improving active substance is encapsulated.
  • oleanolic acid and 1 to 30 parts by weight of a solubilizing agent are mixed with stirring to prepare a first mixture of oleanolic acid, and dissolution of poorly soluble oleoanic acid
  • auxiliary solubilizing agent is preferentially dispersed and mixed in the oleoanilic acid.
  • the first step is to weigh the oleanolic acid and the dissolution aid at the mixing ratio, and then mix with stirring using an agitator, and the stirring temperature can be treated at room temperature (15 to 25 ° C).
  • the second step 1 to 30 parts by weight of an amphiphilic polymer is added to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture, And solubilizing the oleanolic acid into the bi-hydrophilic polymer.
  • the stirring mixture of the first oleanolic acid mixture and the biodegradable polymer is preferably carried out in a warmed state for the purpose of solubilizing the oleanolic acid, and the heating temperature is preferably maintained at 30 to 80 ° C.
  • the third step 39 to 97.99 parts by weight of distilled water is added to the oleanolic acid mixture (2) and stirred to prepare a nanoparticle useful product.
  • the oleanolic acid solubilized in the second step is dissolved in a micelle- It is the process of making things.
  • the distilled water serves as a solvent for dissolving the oleanolic acid, the dissolution aid, and the biodegradable polymer.
  • the nanoparticle useful product is mixed with a carrier component contained in a known cosmetic product to produce a cosmetic product.
  • the nanoparticulate product prepared according to the present invention may be mixed with a known Mixing the carrier component and the titration at a mixing ratio to prepare a cosmetic product having various formulations.
  • the cosmetic according to the present invention can be used as an active ingredient of cosmetics which can be classified into kinds such as skin, toner, essence, emulsion, lotion, cream, face mist, cleansing or face pack emulsion and the like. That is, the cosmetics of the above kind may be classified according to the formulations, and may further comprise various kinds of carrier components for forming the respective formulations, using the cosmetic composition according to the present invention as an active ingredient.
  • the carrier component may be animal fiber, plant fiber, wax, paraffin, starch , Talc, a cellulose derivative, polyethylene glycol, silicon, bentonite, silica, talc or zinc oxide may be used.
  • the carrier component may be lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder May be used, and in addition, if the formulation is a spray, it may further comprise at least one propellant selected from the group consisting of chlorofluorohydrocarbons, propane / butane, and dimethyl ether.
  • the carrier component may be a solvent, a solubilizing agent or an emulsifying agent. More specifically, the carrier component is selected from the group consisting of water, ethanol, isopropanol, ethylcarbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters It can be more than one.
  • the carrier component may be a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, A suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant may be used.
  • the carrier component is selected from aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, A fatty acid amide ether sulfate, an alkylamidobetaine, an aliphatic alcohol, a fatty acid glyceride, a fatty acid diethanolamide, a vegetable oil, a linolen derivative, or an ethoxylated glycerol fatty acid Esters may be used.
  • the carrier component of this kind can be mixed with cosmetics according to the invention (serving as an active ingredient of the cosmetics to be produced) in various mixing ratios, depending on the use of the cosmetics to be produced, Known techniques can be appropriately applied.
  • oleanolic acid 50 mg, oleanolic acid, and 2000 mg of polyethylene glycol (PEG400) are mixed with stirring to prepare a first mixture of oleanolic acid.
  • PEG400 polyethylene glycol
  • Poloxamer 407 F127 was added to the first oleanolic acid mixture prepared in the first step, and the mixture was heated and stirred at 60 ° C to prepare a second oleanolic acid mixture.
  • Nanoparticulate preparations prepared according to Example 1 are each administered to the skin surface.
  • test solutions according to Example 1 were sampled at 1, 2, 4, 6, 8, 10, 20, and 24 hours using 1 ml of receptor phase using a syringe. Respectively.
  • the permeation amount of the nanoparticle-containing particles containing oleic acid per hour was measured by HPLC and the peak area was determined. After calculating the concentration of each of the test solutions according to Example 1, the permeation amount of the skin was calculated.
  • the transdermal permeability increased with time, and it was confirmed that about 15% of the nanoparticle-containing particles containing oleoanic acid were permeated for 24 hours, and less than about 10% of the accumulated amount was accumulated in the skin.
  • the cosmetic product according to the present invention as described above can improve the skin permeation effect of oleanolic acid having the effect of improving the wrinkles of skin through the use of the nanoparticles of oleic acid in the solubilized and micellized state, There is a high possibility.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic for reducing skin wrinkles and, more specifically, to an antiaging cosmetic containing a nanoparticle soluble product obtained by solubilizing and micellizing, with an amphiphilic polymer, oleanolic acid, which is effective for reducing skin wrinkles but is poorly soluble, thereby increasing the solubility thereof in water, which is a solvent contained in cosmetics, and improving skin penetration.

Description

난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품 및 항노화 화장품 제조방법An anti-aging cosmetic and an anti-aging cosmetic manufacturing method comprising a nanoparticle-containing solubilized soluble oleanolic acid
본 발명은 피부 주름개선을 위한 화장품에 관한 것으로서, 보다 상세하면 피부 주름개선 효과가 있지만 난용성 물질인 올레아노릭산을 양쪽 친매성 폴리머로 가용화 및 마이셀화시켜, 화장품에 포함되는 용매인 물에 대한 용해도를 높이고 피부 투과력을 향상시킨 나노입자 유용물을 포함하는 항노화 화장품에 관한 분야이다.More specifically, the present invention relates to a cosmetic for improving skin wrinkles. More specifically, the present invention relates to a cosmetic preparation for improving skin wrinkles, which comprises solubilizing and micellizing oleanolic acid as an insoluble polymer, This invention relates to an anti-aging cosmetic comprising nanoparticles useful for increasing solubility and improving skin permeability.
피부노화는 크게 두 가지 과정을 통해 발생하는데, 특별한 환경적 요인 없이 누구에게나 세월과 함께 일어나는 변화를 내인성 노화라 하고, 자외선 조사와 같은 환경요인에 장기간 노출되어 얼굴, 목, 손 등에 나타나는 변화를 광 노화(Photo aging) 혹은 외인성 노화라고 한다.Skin aging occurs through two main processes. The change that occurs with age without any special environmental factors is called intrinsic aging, and the change in appearance on the face, neck, and hands due to long exposure to environmental factors such as ultraviolet light It is called photo aging or extrinsic aging.
아울러 상기 내인성 노화의 주원인은 우리 몸의 신진대사과정에서 만들어진 반응성 활성 산소 라디칼에 의하여 우리 몸의 구성 성분에 생기는 손상이 누적되기 때문이다. 반면에, 외인성 노화는 유해한 활성산소가 자외선에 의하여 만들어진다는 점에서 차이가 있다. 일단 활성산소가 만들어진 후 몸속에 있는 여러 가지 보호 장치에 의하여 효과적으로 제거되지 못하게 되면 일련의 염증반응이 일어나 피부 손상이 초래되며, 상기 피부 손상 중 대표적인 손상으로는 피부 주름형성이 있다.In addition, the main cause of the endogenous aging is the accumulation of damage to the constituents of the body due to reactive oxygen radicals produced in the metabolism of the body. On the other hand, extrinsic aging is different in that harmful free radicals are produced by ultraviolet rays. Once active oxygen is produced, failure to effectively remove by various protective devices in the body results in a series of inflammatory reactions leading to skin damage, and typical damage to the skin is wrinkled skin.
또한 상기 피부 주름개선을 위해서 아스코르브산, α-토코페롤, 레티놀 및 그 유도체, 수퍼옥사이드 디스뮤타아제(Super Oxide Dismutase, SOD) 등이 자유 라디칼 소거 기능 또는 피부 주름개선을 위한 물질로 화장품에 혼합되어 주름 및 기타 피부 질환을 방지하기 위하여 사용되어 왔으나, 이들은 장기 안정성이 좋지 못하여 실질적인 효과를 기대하기 어려운 문제점이 있다. 이러한 이유로 보다 안전하면서 피부 주름개선에 효과가 높은 물질을 개발하는 것이 화장품 산업 분야에서 중요한 과제로 대두되어 많은 연구가 진행되고 있다.In order to improve the skin wrinkles, ascorbic acid,? -Tocopherol, retinol and derivatives thereof, superoxide dismutase (SOD) and the like are mixed with cosmetics as a substance for free radical scavenging function or skin wrinkle improvement, And other skin diseases. However, they have poor long-term stability and are hard to expect a substantial effect. For this reason, development of a material which is more safe and effective for improving the wrinkles of the skin has become an important task in the cosmetics industry, and many studies have been conducted.
더불어 레티놀(Retinol)은 화장품에 포함되어, 피부 주름개선 효과를 가지는 물질로 널리 알려져 있으나, 열이나 빛에 약하고, 광과민성이라 햇빛에 노출되면 피부를 더욱 예민하게 만들 수 있는 문제가 제시되고 있다.In addition, retinol is widely known as a substance having a wrinkle-reducing effect in cosmetics, but it is vulnerable to heat or light, and it is photosensitive, so that a problem of making the skin more sensitive when exposed to sunlight is suggested.
상기와 연관하여, 최근에는 상기 레티놀의 대안 물질로서 올레아노릭산이 제시되고 있으나, 상기 올레아노릭산은 물과 같은 용매에 거의 용해되지 못하는 난용성을 가져 물을 용매로 사용하는 일반적인 화장품에 가용화시키기 어려운 문제가 있었고, In recent years, oleanolic acid has been proposed as an alternative to retinol. However, the oleanolic acid has poor solubility in a solvent such as water and solubilized in general cosmetics using water as a solvent There was a difficult problem,
그러나 일반적 방법인 오일, 계면활성제 및 용해제를 사용해 올레아노릭산을 가용화시켜 화장품을 제조하면 침전이나 입자가 커서 피부투과가 어려운 문제가 있었다.However, when oleic acid is solubilized using oils, surfactants, and solubilizers as a general method, cosmetic products have problems of difficulty in permeation of the skin due to large sedimentation and particles.
다음은 피부 주름개선 기능을 가지는 화장품에 관한 대표적인 종래기술이다.The following are representative prior arts relating to cosmetic products having the function of improving skin wrinkles.
대한민국 등록특허공보 제10-1802963호는 발효 추출물을 이용한 화장료 조성물에 관한 것으로서, 홍삼 및 고삼을 포함하는 약재 발효 추출물; 유지 발효 추출물; 및 콩 발효 추출물을 포함하는 화장료 조성물을 제공한다. 본 발명에 따르면, 천연 약재, 유지, 및 콩 발효 추출물을 유효성분으로 포함하는 구성을 하고, 상기 화장료 조성물은 피부 모공 수축제로써 올레아노릭산을 더 포함하는 구성을 할 수 있다.Korean Patent Registration No. 10-1802963 relates to a cosmetic composition using a fermented extract, which comprises a fermented extract of a medicinal substance containing red ginseng and ginseng; Sustained fermentation extract; And a soybean fermentation extract. According to the present invention, it is possible to constitute a composition containing natural medicinal materials, fat, soybean fermented extract as an active ingredient, and the cosmetic composition further comprises oleoanic acid as a skin pore filling agent.
또한 상기 종래기술에 의한 화장료 조성물은 천연 약재, 유지, 및 콩 발효 추출물을 유효성분으로 포함하여, 피부 노화 방지 및 주름 완화 등의 피부 개선 효과를 실현시킬 수 있었으나, 화장료의 주된 용제인 물에 대한 피부 모공 수축제로 사용되는 상기 올레아노릭산의 가용성이 매우 미흡한 문제가 있어서, 이를 해결하기 위한 지속적인 연구개발이 요구되는 실정이다.In addition, the cosmetic composition according to the above-mentioned prior art can provide a skin-improving effect such as prevention of skin aging and alleviation of wrinkles by including a natural medicinal material, a fat and a fermented soybean extract as an active ingredient. However, There is a problem that the oleanolic acid used as a pore-shrinking agent of the skin is very insufficient in availability. Therefore, there is a need for continuous research and development for solving the problem.
<선행기술문헌><Prior Art Literature>
대한민국 등록특허공보 제10-1802963호(2017.11.23.)Korean Registered Patent No. 10-1802963 (November 23, 2017)
대한민국 등록특허공보 제10-1565908호(2015.10.29.)Korean Registered Patent No. 10-1565908 (Oct. 29, 2015)
대한민국 공개특허공보 제10-2017-0003400호(2017.01.09.)Korean Patent Publication No. 10-2017-0003400 (2017.01.09.)
대한민국 등록특허공보 제10-0891260호(2009.03.24.)Korean Registered Patent No. 10-0891260 (Mar. 24, 2009)
본 발명은 화장품의 종래기술에 따른 문제점들을 개선하고자 안출된 기술로서, 피부 주름개선 효과를 가지는 난용성 올레아노릭산의 가용성을 향상시키고, 마이셀화된 올레아노릭산을 포함하는 나노입자 유용물이 포함된 화장품을 제공하는 것을 목적으로 한다.The present invention relates to a cosmetic composition for improving the solubility of an insoluble oleanolic acid having the effect of improving skin wrinkles and containing nanoparticulate products containing micellized oleoanic acid Cosmetics, and the like.
본 발명은 상기와 같은 소기의 목적을 실현하고자,The present invention has been made to solve the above-
올레아노릭산(Oleanolic Acid) 0.01 내지 1 중량부, 용해 보조제 1 내지 30 중량부, Amphiphilic polymer(폴록사머류) 1 내지 30 중량부 및 증류수 39 내지 97.99 중량부를 포함하여 구성되는 나노입자 유용물을 포함하여 구성되는 항노화 화장품을 제시하고,0.01 to 1 part by weight of oleanolic acid, 1 to 30 parts by weight of a solubilizer, 1 to 30 parts by weight of an amphiphilic polymer (Poloxamer) and 39 to 97.99 parts by weight of distilled water, The present invention relates to an anti-aging cosmetic composition,
올레아노릭산(Oleanolic Acid) 0.01 내지 1 중량부와 용해 보조제 1 내지 30 중량부를 교반 혼합하여 올레아노릭산 제1혼합물을 만드는 제1단계; 상기 올레아노릭산 제1혼합물에 Amphiphilic polymer(폴록사머류) 1 내지 30 중량부를 추가한 후 가온 상태에서 교반 혼합하여 올레아노릭산 제2혼합물을 만드는 제2단계; 상기 올레아노릭산 제2혼합물에 증류수 39 내지 97.99 중량부를 추가한 후 교반 혼합하여 나노입자 유용물을 만드는 제3단계 및; 상기 나노입자 유용물을 공지의 화장품에 포함되는 담체 성분과 혼합하여 화장품을 만드는 제4단계;를 포함하여 구성되는 항노화 화장품 제조방법을 제시한다.0.01 to 1 part by weight of oleanolic acid and 1 to 30 parts by weight of a solubilizing agent are mixed with stirring to prepare a first mixture of oleanolic acid; A second step of adding 1 to 30 parts by weight of an amphiphilic polymer (Poloxamer) to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture; A third step of adding 39 to 97.99 parts by weight of distilled water to the oleanolic acid second mixture, followed by stirring and mixing to produce a nanoparticle useful product; And a fourth step of mixing the nanoparticle useful product with a carrier component contained in a known cosmetic product to produce a cosmetic product.
상기와 같이 제시된 본 발명에 의한 화장품은 올레아노릭산이 가용화 및 마이셀화된 상태로 이루어진 나노입자 유용물을 통하여, 피부 주름개선 효과가 있는 올레아노릭산의 피부 투과효과를 향상시킬 수 있다.The cosmetic according to the present invention as described above can enhance the skin permeation effect of oleanolic acid having the effect of improving the wrinkles of the skin through the nanoparticulate product in which oleic acid is solubilized and micellized.
도 1은 본 발명의 바람직한 실시예1에 의한 난용성 올레아노릭산을 가용화한 나노입자 유용물의 안정성 실험 결과이다.FIG. 1 shows the stability test results of nanoparticulate solubilizing insoluble oleoanic acid according to the first embodiment of the present invention.
도 2는 본 발명의 바람직한 실시예 1에 의한 난용성 올레아노릭산을 가용화한 나노입자 유용물의 피부투과시험 과정을 나타내는 이미지이다.FIG. 2 is an image showing a skin permeation test procedure of the nanoparticle useful solubilized with poorly soluble oleoanic acid according to the first embodiment of the present invention. FIG.
도 3는 본 발명의 바람직한 실시예 1에 의한 난용성 올레아노릭산을 가용화한 나노입자 유용물의 피부투과시험 결과를 나타내는 그래프이다.FIG. 3 is a graph showing the results of skin permeation test of nanoparticulate products solubilized with poorly soluble oleoanic acid according to the first embodiment of the present invention.
이하, 본 발명을 첨부한 도면을 참고하여 구체적으로 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
<난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품><Anti-aging cosmetics containing nanoparticles useful in solubilization of poorly soluble oleanolic acid>
올레아노릭산(Oleanolic Acid) 0.01내지 1 중량부, 용해 보조제 1 내지 30 중량부, Amphiphilic polymer(폴록사머류) 1 내지 30 중량부 및 증류수 39 내지 97.99 중량부를 포함하여 구성되는 나노입자 유용물을 포함하는, 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품에 관한 것이다. 이때, 상기 나노입자 유용물은 피부에 대한 투과력을 향상시키 위하여 20~150nm 입자크기를 갖는 것이 바람직하다.0.01 to 1 part by weight of oleanolic acid, 1 to 30 parts by weight of a solubilizer, 1 to 30 parts by weight of an amphiphilic polymer (Poloxamer) and 39 to 97.99 parts by weight of distilled water To an anti-aging cosmetic comprising nanoparticulate solubilizing solubilized oleanolic acid. At this time, it is preferable that the nanoparticle-containing material has a particle size of 20 to 150 nm in order to improve permeability to the skin.
상기 올레아노릭산(Oleanolic Acid)은 항산화 효과가 있는 물질로 알려져 있고, 본 발명에 있어서는 항상화 효과에 기인한 피부 주름개선 효과를 발휘하는 물질이다.Oleanolic acid is known as a substance having an antioxidative effect. In the present invention, it is a substance exhibiting an effect of improving skin wrinkles due to the constantly effective action.
또한 종래 피부 주름개선 효과 물질로 알려진 레티놀(Retinol)은 화장품의 유효물질로 포함된 경우, 열이나 빛에 불안정하고, 공기에 닿으면 효능이 반감되는 단점이 있었으나, 상기 올레아노릭산(Oleanolic Acid)은 레티놀의 단점을 개선할 수 있는 대체 유효물질로 제시되고 있다.Retinol, which is known as a skin wrinkle-reducing substance, has a disadvantage in that it is unstable to heat or light and its effectiveness is reduced by half when it is contained as an effective substance in cosmetics. However, when the oleanolic acid is used, Has been proposed as an alternative effective substance that can improve the disadvantages of retinol.
하지만 상기 올레아노릭산(Oleanolic Acid)은 난용성이기 때문에 화장품의 주된 성분인 물에 거의 용해되지 않고, 입자가 커서 피부에 투과되기 어려운 문제가 있었다. 이에 대하여, 본 발명은 상기 올레아노릭산(Oleanolic Acid)에 용해 보조제 및 양쪽 친매성의 폴리머(Amphiphilic polymer)를 혼합하여 가용성의 마이셀 형태로 유리하게 반응할 수 있도록 만들고, 상기와 같이 마이셀화된 올레아노릭산을 증류수에 용해시켜 화장품으로 만들 수 있도록 하였다.However, Oleanolic Acid is hardly soluble in water, which is a main component of cosmetics, and has a problem that it is difficult to permeate the skin because of its large particle size. On the contrary, the present invention provides a method of preparing a solution of an oleanolic acid by mixing a solution aid and an amphiphilic polymer in the oleanolic acid so as to be able to react favorably in a soluble micelle form, Anionic acid was dissolved in distilled water to make cosmetics.
아울러 상기 용해 보조제는 상기 올레아노릭산을 마이셀화시키기 위하여 용해제인 양쪽 친매성의 폴리머의 보조제 역할을 한다.In addition, the solubilizer serves as an adjuvant for both hydrophilic polymers which are dissolvers to micellize the oleoanic acid.
이때, 상기 용해 보조제는 에틸렌글리콜, 프로필렌글라이콜카프릴레이트, 테트라에틸렌글리콜, 폴리에틸렌글리콜, 폴리프로필렌글리콜 또는 폴리부틸렌글리콜 중 어느 하나 이상의 것을 이용할 수 있고, 바람직하게는 상기 에틸렌글리콜 또는 프로필렌글라이콜카프릴레이트 중 어느 하나를 이용할 수 있다.At this time, the dissolution aid may be any one or more of ethylene glycol, propylene glycol monocaprylate, tetraethylene glycol, polyethylene glycol, polypropylene glycol and polybutylene glycol, preferably ethylene glycol or propylene glycol And cocaprylate may be used.
또한 상기 용해 보조제는 상기 올레아노릭산 0.05 내지 1 중량부에 대하여 1 내지 30 중량부를 사용할 수 있고, 2 내지 10 중량부를 사용하는 것이 바람직하다. 만약, 상기 용해 보조제가 올레아노릭산 1 중량부에 대하여 1 중량부 미만으로 함유되는 경우에는 올레아노릭산의 분산이 불완전해 추후 화장품의 사용시 올레아노릭산의 방출이 어려워지는 문제가 있고, 올레아노릭산 1 중량부에 대하여 30 중량부를 초과하는 경우에는 올레아노릭산의 안정성 개선이 미비하여 시약이 낭비되는 문제가 있다.The dissolution aid may be used in an amount of 1 to 30 parts by weight, preferably 2 to 10 parts by weight, based on 0.05 to 1 part by weight of the oleanolic acid. If the solubilizing agent is contained in an amount of less than 1 part by weight based on 1 part by weight of the oleanolic acid, the dispersion of the oleanolic acid is incomplete and the release of the oleoanic acid becomes difficult at the time of use of the cosmetic, When the amount is more than 30 parts by weight based on 1 part by weight, there is a problem that the stability of the oleanolic acid is insufficient and the reagent is wasted.
더불어 상기 용해 보조제에 의한 올레아노릭산의 용해도를 더욱 향상시키기 위하여 글리코푸롤, 폴리소르베이트, 크레모포어, 솔루톨 HS(Solutol HS 15) 등을 더 혼합하여 사용할 수 있다.In order to further improve the solubility of the oleanolic acid by the solubilizing aid, it is possible to further use glycofurol, polysorbate, crmolpore, Solutol HS 15 and the like.
아울러 상기 양쪽 친매성의 폴리머(Amphiphilic polymer)는 마이셀 형성의 역할을 수행하고, 바람직하게는 <폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)> 형태의 트리블록 공중합체류를 이용할 수 있으며, 더욱 바람직하게는 폴록사머 184, 폴록사머 185, 폴록사머 188, 폴록사머 124, 폴록사머 237, 폴록사머 338 또는 폴록사머 407 중 어느 하나 이상의 것을 이용할 수 있다.In addition, the amphiphilic polymer plays a role of micelle formation and preferably triblock copolymers in the form of <polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)> More preferably, at least one of Poloxamer 184, Poloxamer 185, Poloxamer 188, Poloxamer 124, Poloxamer 237, Poloxamer 338 or Poloxamer 407 can be used.
상기와 연관하여, 상기 트리블록 공중합체류는 올레아노릭산 0.01 내지 1 중량부에 대하여 1 내지 30 중량부로 함유되는 것이 바람직하고, 5 내지 20 중량부로 함유되는 것이 더욱 바람직하다. 만약, 상기 트리블록 공중합체류가 올레아노릭산 0.01 내지 1 중량부에 대하여 1 중량부 미만으로 함유되는 경우에는 올레아노릭산의 침전이 발생하는 문제가 있고, 올레아노릭산 1 중량부에 대하여 30 중량부를 초과하는 경우에는 입자크기가 증가하여 안정성이 떨어지는 문제가 있다.In connection with the above, the triblock copolymer is preferably contained in an amount of 1 to 30 parts by weight, more preferably 5 to 20 parts by weight, based on 0.01 to 1 part by weight of oleic acid. If the triblock copolymer is contained in an amount of less than 1 part by weight based on 0.01 to 1 part by weight of oleanolic acid, there is a problem that precipitation of oleanolic acid occurs, and when the amount of the triblock copolymer is 30 parts by weight per 1 part by weight of oleanolic acid There is a problem that the particle size is increased and the stability is lowered.
더불어 상기 양쪽 친매성의 폴리머는 상기 범위 내의 혼합비에서 혼합비가 높아수록 만들어진 나노입자 유용물이 겔 형태의 것으로 만들어지고, 혼합비가 낮아질수록 만들어진 나노입자 유용뮬이 액상 형태의 것으로 만들어질 수 있다.In addition, both of the above-mentioned biocompatible polymers have a high mixing ratio within the above-mentioned mixing ratio, so that the nanoparticle useful product is made into a gel-like form, and as the mixing ratio is lowered, the prepared nanoparticle-containing mule can be made into a liquid form.
또한 상기 증류수는 상기 올레아노릭산, 용해 보조제 및 양쪽 친매성의 폴리머를 용해시키는 용매 역할을 하는 구성이다.Further, the distilled water serves as a solvent for dissolving the oleanolic acid, the dissolution aid, and the biodegradable polymer.
이때, 상기 증류수는 올레아노릭산 0.01 내지 1중량부에 대하여 39내지 97.99중량부로 함유되는 것이 바람직하다. At this time, the distilled water is preferably contained in an amount of 39 to 97.99 parts by weight based on 0.01 to 1 part by weight of oleic acid.
만약, 상기 증류수가 올레아노릭산 0.01 내지 1 중량부에 대하여 39 중량부 미만으로 함유되는 경우에는 올레아노릭산의 마이셀화가 완전히 이루어지지 못하는 문제가 있고, 올레아노릭산 0.01 내지 1 중량부에 대하여 98 중량부를 초과하는 경우에는 만들어진 나노입자 유용물의 농도가 지나치게 낮아질 수 있는 문제가 있다.If the distilled water contains less than 39 parts by weight of oleanolic acid based on 0.01 to 1 part by weight of the oleanolic acid, there is a problem that the oleanolic acid is not fully micellized. When 0.01 to 1 part by weight of oleanolic acid is used, There is a problem that the concentration of the produced nanoparticle useful substance may be excessively lowered.
상기와 연관하여, 상기 올레아노릭산, 용해 보조제, 양쪽 친매성의 폴리머 및 증류수는 일괄적으로 혼합되어 나노입자 유용물로 만들어지는 구성을 할 수도 있지만, 바람직하게는 상기 올레아노릭산, 용해 보조제는 교반 혼합되어 올레아노릭산 제1혼합물로 만들어지고, 상기 올레아노릭산 제1혼합물에는 상기 양쪽 친매성의 폴리머가 첨가된 이후 가온 상태에서 교반 혼합되어 올레아노릭산 제2혼합물이 만들어지며, 상기 올레아노릭산 제2혼합물에는 상기 증류수가 혼합되어 상기 나노입자 유용물이 만들어질 수 있다.In connection with the above, the oleanolic acid, the solubilizing aid, the amphiphilic polymer, and the distilled water may be mixed together to form the nanoparticle useful product, but preferably the oleanolic acid and the dissolution aid The oleanolic acid first mixture is added to the oleanolic acid first mixture and then the two ampholytic polymers are added to the oleanolic acid first mixture, and then the mixture is stirred under heating to prepare a second oleanolic acid mixture, The second mixture of ricinic acid may be mixed with the distilled water to make the nanoparticle useful product.
즉, 상기 올레아노릭산 제1혼합물은 올레아노릭산과 용해 보조제의 교반 혼합으로 이루어지는 구성으로서, 상기 용해 보조제를 우선적으로 올레아노릭산에 분산시키며 혼합시키기 위한 구성이다.That is, the first oleanolic acid mixture is composed of an oleanolic acid and a solubilizing agent mixed with stirring, and the solubilizing agent is preferentially dispersed and mixed in oleic acid.
보다 상세하면, 상기와 같이 용해 보조제가 올레아노릭산에 우선 분산 혼합되면, 마이셀을 주되게 형성시키는 양쪽 친매성의 폴리머가 올레이노릭산과 반응하기 이전에 용해 보조제가 먼저 올레아노릭산의 입자들 사이에 균일하게 분산되어 있는 효과를 발휘하여, 올레아노릭산의 마이셀화를 향상시킬 수 있는 효과를 얻을 수 있다.More specifically, when the dissolution aid is first dispersed in the oleanolic acid, the dissolution aid is first dissolved in the mixture of the oleanolic acid particles before the bilayer fibrillating polymer which mainly forms the micelle reacts with the oleinic acid, It is possible to obtain an effect of improving the micelle formation of oleanolic acid.
아울러 상기 올레아노릭산 제2혼합물은 상기 올레아노릭산 제1혼합물에 양쪽 친매성의 폴리머를 혼합하여 만들어지는 구성으로서, 올레아노릭산 제1혼합물에 포함된 올레아노릭산을 가온하여 반응 활성도를 향상시킴으로써 난용성의 올레아노릭산의 가용화를 증대시키기 위한 구성이다.The oleanolic acid second mixture may be prepared by mixing the first oleanolic acid mixture with a biocompatible polymer. The oleanolic acid contained in the first mixture of oleanolic acid may be heated to improve the reaction activity And is a constitution for increasing the solubilization of oleanolic acid having poor solubility.
이때, 상기 올레아노릭산 제2혼합물을 만들기 위한 가온 온도는 30~80℃로 유지되는 것이 바람직하다.At this time, it is preferable that the heating temperature for making the oleanolic acid second mixture is maintained at 30 to 80 캜.
즉, 상기 가온 온도가 30℃ 미만이면, 올레아노릭산의 반응 활성도가 다소 미흡하고, 80℃를 초과하면 올레아노릭산이 변질될 우려가 있기 때문이다.That is, if the heating temperature is less than 30 ° C, the reaction activity of oleanolic acid is somewhat insufficient, and if it exceeds 80 ° C, the oleanolic acid may be deteriorated.
<난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품 제조방법><Method for producing anti-aging cosmetics containing nanoparticles useful for solubilization of poorly soluble oleanolic acid>
본 발명은 올레아노릭산(Oleanolic Acid) 0.01내지 1 중량부와 용해 보조제 1 내지 30 중량부를 교반 혼합하여 올레아노릭산 제1혼합물을 만드는 제1단계; 상기 올레아노릭산 제1혼합물에 양쪽 친매성의 폴리머(Amphiphilic polymer) 1 내지 30 중량부를 추가한 후 가온 상태에서 교반 혼합하여 올레아노릭산 제2혼합물을 만드는 제2단계; 상기 올레아노릭산 제2혼합물에 증류수 39 내지 97.99 중량부를 추가한 후 교반 혼합하여 나노입자 유용물을 만드는 제3단계 및; 상기 나노입자 유용물을 공지의 화장품에 포함되는 담체 성분과 혼합하여 화장품을 만드는 제4단계;를 포함하여 구성되는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품 제조방법에 관한 것이다.The present invention relates to a method for producing an oleanolic acid, comprising: a first step of mixing 0.01 to 1 part by weight of oleanolic acid and 1 to 30 parts by weight of a solubilizing agent with stirring to prepare a first mixture of oleanolic acid; A second step of adding 1 to 30 parts by weight of an amphiphilic polymer to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture; A third step of adding 39 to 97.99 parts by weight of distilled water to the oleanolic acid second mixture, followed by stirring and mixing to form a nanoparticle useful product; And a fourth step of preparing a cosmetic product by mixing the nanoparticulate useful product with a carrier component contained in a known cosmetic product. The method for manufacturing an anti-aging cosmetic product comprising the nanoparticulate product obtained by solubilizing the poorly soluble oleoanic acid .
본 발명에 따른 화장품 제조방법은, 미백개선 유효물질이 봉입된 20 내지 150 nm 입자크기를 가지는 나노입자 유용물를 포함하는 화장품을 제조할 수 있다.The method of manufacturing a cosmetic product according to the present invention can produce a cosmetic product containing a nanoparticle useful product having a particle size of 20 to 150 nm in which the whitening improving active substance is encapsulated.
즉, 상기 제1단계는 올레아노릭산(Oleanolic Acid) 0.01내지 1 중량부와 용해 보조제 1 내지 30 중량부를 교반 혼합하여 올레아노릭산 제1혼합물을 만드는 과정으로서, 난용성의 올레아노릭산의 용해를 보조하는 용해 보조제를 올레아노릭산에 우선적으로 분산 혼합시키는 과정이다.That is, in the first step, 0.01 to 1 part by weight of oleanolic acid and 1 to 30 parts by weight of a solubilizing agent are mixed with stirring to prepare a first mixture of oleanolic acid, and dissolution of poorly soluble oleoanic acid And the auxiliary solubilizing agent is preferentially dispersed and mixed in the oleoanilic acid.
이때, 상기 제1단계는 상기 혼합비의 올레아노릭산과 용해 보조제를 칭량한 후 교반기를 이용하여 교반 혼합하는 것이 바람직하고, 교반 온도는 상온(15~25℃)에서 처리 가능하다.At this time, the first step is to weigh the oleanolic acid and the dissolution aid at the mixing ratio, and then mix with stirring using an agitator, and the stirring temperature can be treated at room temperature (15 to 25 ° C).
또한 상기 제2단계는 상기 올레아노릭산 제1혼합물에 양쪽 친매성의 폴리머(Amphiphilic polymer) 1 내지 30 중량부를 추가한 후 가온 상태에서 교반 혼합하여 올레아노릭산 제2혼합물을 만드는 과정으로서, 난용성인 올레아노릭산을 상기 양쪽 친매성의 폴리머로 가용화시키는 과정이다.In the second step, 1 to 30 parts by weight of an amphiphilic polymer is added to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture, And solubilizing the oleanolic acid into the bi-hydrophilic polymer.
즉, 상기 양쪽 친매성의 폴리머에 관한 구체적인 설명은 상기의 설명으로 대신하겠다. 다만, 올레아노릭산 제1혼합물과 양쪽 친매성의 폴리머의 교반 혼합은 올레아노릭산의 가용화 향성을 위하여 가온 상태에서 이루어지는 것이 바람직하고, 이때, 가온 온도는 30~80℃로 유지되는 것이 바람직하다.That is, the description of the both hydrophilic polymers will be replaced by the above description. However, the stirring mixture of the first oleanolic acid mixture and the biodegradable polymer is preferably carried out in a warmed state for the purpose of solubilizing the oleanolic acid, and the heating temperature is preferably maintained at 30 to 80 ° C.
아울러 상기 제3단계는 상기 올레아노릭산 제2혼합물에 증류수 39 내지 97.99 중량부를 추가한 후 교반 혼합하여 나노입자 유용물을 만드는 과정으로서, 상기 제2단계에서 가용화된 상기 올레이노릭산을 마이셀 형태의 것을 만드는 과정이다.In the third step, 39 to 97.99 parts by weight of distilled water is added to the oleanolic acid mixture (2) and stirred to prepare a nanoparticle useful product. The oleanolic acid solubilized in the second step is dissolved in a micelle- It is the process of making things.
이때, 상기 증류수는 상기 올레아노릭산, 용해 보조제 및 양쪽 친매성의 폴리머를 용해시키는 용매 역할을 하는 구성이다.At this time, the distilled water serves as a solvent for dissolving the oleanolic acid, the dissolution aid, and the biodegradable polymer.
더불어 상기 제4단계는 상기 나노입자 유용물을 공지의 화장품에 포함되는 담체 성분과 혼합하여 화장품을 만드는 과정으로서, 본 발명에 의하여 제조된 상기 나노입자 유용물을 화장품의 제형에 따라 서로 다른 공지의 담체 성분과 적정의 혼합비로 혼합하여, 다양한 제형으로 이루어진 화장품을 제조하는 과정이다.In the fourth step, the nanoparticle useful product is mixed with a carrier component contained in a known cosmetic product to produce a cosmetic product. The nanoparticulate product prepared according to the present invention may be mixed with a known Mixing the carrier component and the titration at a mixing ratio to prepare a cosmetic product having various formulations.
구체적으로, 또한 본 발명에 의한 화장품은 스킨, 토너, 에센스, 에멀젼, 로션, 크림, 페이스 미스트, 클렌징 또는 페이스 팩의 에멀젼 등과 같은 종류의 것으로 구분될 수 있는 화장품의 유효성분으로서 사용될 수 있다. 즉, 상기 종류의 화장품은 제형에 따라 구분되어 본 발명에 의한 화장품을 유효성분으로 하고 각각의 제형을 이루기 위한 다양한 종류의 담체 성분을 더 포함하는 구성을 할 수 있다.Specifically, the cosmetic according to the present invention can be used as an active ingredient of cosmetics which can be classified into kinds such as skin, toner, essence, emulsion, lotion, cream, face mist, cleansing or face pack emulsion and the like. That is, the cosmetics of the above kind may be classified according to the formulations, and may further comprise various kinds of carrier components for forming the respective formulations, using the cosmetic composition according to the present invention as an active ingredient.
바람직하게는, 본 발명에 의한 상기 나노입자 유용물을 유효성분으로 하고, 제조되는 항노화 화장품의 제형이 페이스트, 크림 또는 겔인 경우에는, 상기 담체 성분은 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 중 어느 하나 이상의 것이 이용될 수 있다.Preferably, when the nanoparticulate useful product according to the present invention is used as an active ingredient and the formulation of the anti-aging cosmetic product is paste, cream or gel, the carrier component may be animal fiber, plant fiber, wax, paraffin, starch , Talc, a cellulose derivative, polyethylene glycol, silicon, bentonite, silica, talc or zinc oxide may be used.
또한 본 발명에 의한 상기 나노입자 유용물을 유효성분으로 하고, 제조되는 화장품의 제형이 파우더 또는 스프레이인 경우에는, 상기 담체 성분은 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더 중 어느 하나 이상의 것이 이용될 수 있고, 특히 제형이 스프레이인 경우에는 추가적으로 클로로 플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르 중 어느 하나 이상의 추진체를 더 포함할 수 있다.Also, when the nanoparticle useful product according to the present invention is used as an active ingredient and the formulation of the cosmetic product is a powder or a spray, the carrier component may be lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder May be used, and in addition, if the formulation is a spray, it may further comprise at least one propellant selected from the group consisting of chlorofluorohydrocarbons, propane / butane, and dimethyl ether.
아울러 본 발명에 의한 상기 나노입자 유용물을 유효성분으로 하고, 제조되는 화장품의 제형이 용액 또는 유탁액의 경우에는, 상기 담체 성분은 용매, 용매화제 또는 유탁화제가 이용될 수 있다. 보다 상세하면 상기 담체 성분은 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 중 어느 하나 이상의 것이 될 수 있다.In addition, in the case where the nanoparticle useful product according to the present invention is used as an active ingredient and the formulation of the cosmetic product is a solution or an emulsion, the carrier component may be a solvent, a solubilizing agent or an emulsifying agent. More specifically, the carrier component is selected from the group consisting of water, ethanol, isopropanol, ethylcarbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters It can be more than one.
더불어 본 발명에 의한 상기 나노입자 유용물을 유효성분으로 하고,, 제조되는 화장품의 제형이 현탁액인 경우에는, 상기 담체 성분은 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타 히드록시드, 벤토나이트, 아가 또는 트라칸트 중 어느 하나 이상의 것이 이용될 수 있다.In addition, when the nanoparticulate useful product of the present invention is used as an active ingredient and the formulation of the cosmetic product is a suspension, the carrier component may be a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, A suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant may be used.
또한 본 발명에 의한 상기 나노입자 유용물을 유효성분으로 하고, 제조되는 화장품의 제형이 계면-활성제 함유 클린징인 경우에는, 상기 담체 성분은 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린유도체 또는 에톡실화 글리세롤 지방산 에스테르 중 어느 하나 이상의 것이 이용될 수 있다.When the nanoparticle useful product according to the present invention is used as an active ingredient and the formulation of the cosmetic product is an interfacial active agent-containing cleansing, the carrier component is selected from aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, A fatty acid amide ether sulfate, an alkylamidobetaine, an aliphatic alcohol, a fatty acid glyceride, a fatty acid diethanolamide, a vegetable oil, a linolen derivative, or an ethoxylated glycerol fatty acid Esters may be used.
상기와 연관하여, 상기 종류의 담체 성분은 제조되는 화장품의 용도에 따라 본 발명에 의한 화장품(제조되는 화장품의 유효성분으로서의 역할을 함.)과 다양한 혼합비로 혼합될 수 있고, 그에 대한 바람직한 혼합비는 공지의 기술을 적절하게 적용할 수 있다.In connection with the above, the carrier component of this kind can be mixed with cosmetics according to the invention (serving as an active ingredient of the cosmetics to be produced) in various mixing ratios, depending on the use of the cosmetics to be produced, Known techniques can be appropriately applied.
이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to examples.
단, 하기 실시예는 본 발명의 예시하는 것일 뿐, 본 발명의 내용이 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following examples are merely illustrative of the present invention, and the content of the present invention is not limited by the examples and the experimental examples.
<실시예 1>&Lt; Example 1 >
1. 제1단계1. Step 1
올레아노릭산 50mg, 폴리에틸렌글리콜(PEG400) 2000mg을 교반 혼합하여, 올레아노릭산 제1혼합물을 만든다.50 mg of oleanolic acid, and 2000 mg of polyethylene glycol (PEG400) are mixed with stirring to prepare a first mixture of oleanolic acid.
2. 제2단계2. Phase 2
상기 제1단계에서 만들어진 올레아노릭산 제1혼합물에 폴록사머 407(F127) 10000mg를 첨가하고, 60℃로 가열하며 교반 혼합하여 올레아노릭산 제2혼합물을 만든다.10000 mg of Poloxamer 407 (F127) was added to the first oleanolic acid mixture prepared in the first step, and the mixture was heated and stirred at 60 ° C to prepare a second oleanolic acid mixture.
3. 제3단계3. Stage 3
상기 제2단게에서 만들어진 올레아노릭산 제2혼합물에 증류수 87950mg을 첨가하고, 교반 혼합하여 액상의 나노입자 유용물을 만든다.87950 mg of distilled water was added to the second oleanolic acid mixture prepared in the second step, and the mixture was stirred and mixed to obtain a liquid nanoparticle useful liquid.
<나노입자 안정성 시험><Nanoparticle Stability Test>
1. 상기 실시예 1에 의하여 제조된 나노입자 유용물을 25℃, 6개월 보관(장기안정성 시험), 40℃, 3개월 보관(가속시험)을 통해 입자의 크기와 함량변화를 측정하여 입자 안정성을 확인하였다. 1. Measurement of particle size and content of nanoparticles prepared according to Example 1 at 25 ° C for 6 months (long-term stability test) and storage at 40 ° C for 3 months (accelerated test) Respectively.
<피부투과시험><Skin permeation test>
1. 사람 피부를 Franz diffusion cell의 donor compartment에 각질층을 향하게 하여 receptor compartment 사이에 끼운다.1. Place the human skin between the receptor compartment with the stratum corneum facing the donor compartment of the Franz diffusion cell.
2. 상기 실시예 1에 의하여 제조된 나노입자 유용물을 피부 표면에 각각 투여한다.2. Nanoparticulate preparations prepared according to Example 1 are each administered to the skin surface.
(receptor compartment 용액은 pH 7.4 인산염과 에탄올(50:50)을 사용하였고 온도는 33 ℃, 600rpm 상태로 유지하였음.)(pH 7.4 phosphate and ethanol (50:50) were used as the receptor compartment solution and the temperature was maintained at 33 ° C and 600 rpm.)
3. 상기 실시예 1에 의한 각각의 검액은 2, 4, 6, 8, 10, 20, 24 시간에 1 ml의 receptor phase를 syringe를 사용하여 채취하였고, 채취된 양은 즉시 동량의 용액으로 receptor에 보충하였다.3. Each of the test solutions according to Example 1 was sampled at 1, 2, 4, 6, 8, 10, 20, and 24 hours using 1 ml of receptor phase using a syringe. Respectively.
4. 시간당 올레아노릭산을 봉입한 나노입자 유용물 입자의 투과량을 HPLC를 통해 측정 후 피크 면적을 구하여 실시예 1에 의한 각각의 검액 농도를 계산 후 피부 투과량을 산출하였다.4. The permeation amount of the nanoparticle-containing particles containing oleic acid per hour was measured by HPLC and the peak area was determined. After calculating the concentration of each of the test solutions according to Example 1, the permeation amount of the skin was calculated.
<시험 결과><Test Results>
도 1와 같이, 나노입자 유용물의 안정성을 5개월동안 입도분석과 함량 분석을 통해 확인하였고, As shown in Fig. 1, the stability of the nanoparticle useful material was confirmed through particle size analysis and content analysis for 5 months,
도 2와 같이, Franz diffusion cell을 이용해 피부투과 시험을 진행하였고, As shown in FIG. 2, skin permeation test was conducted using Franz diffusion cell,
도 3와 같이, 시간에 따라 경피투과율은 증가하였고, 24시간 동안 올레아노릭산을 봉입한 나노입자 유용물 입자가 약 15 % 투과되며, 피부에 약 10 % 미만의 양이 축적됨을 확인할 수 있었다.As shown in FIG. 3, the transdermal permeability increased with time, and it was confirmed that about 15% of the nanoparticle-containing particles containing oleoanic acid were permeated for 24 hours, and less than about 10% of the accumulated amount was accumulated in the skin.
상기는 본 발명의 바람직한 실시예를 참고로 설명하였으며, 상기의 실시예에 한정되지 아니하고, 상기의 실시예를 통해 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 본 발명의 요지를 벗어나지 않는 범위에서 다양한 변경으로 실시할 수 있는 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, It is possible to carry out various changes in the present invention.
상기와 같이 제시된 본 발명에 의한 화장품은 올레아노릭산이 가용화 및 마이셀화된 상태로 이루어진 나노입자 유용물을 통하여, 피부 주름개선 효과가 있는 올레아노릭산의 피부 투과효과를 향상시킬 수 있어 산업상 이용가능성도 높다.The cosmetic product according to the present invention as described above can improve the skin permeation effect of oleanolic acid having the effect of improving the wrinkles of skin through the use of the nanoparticles of oleic acid in the solubilized and micellized state, There is a high possibility.

Claims (5)

  1. 올레아노릭산(Oleanolic Acid) 0.01내지 1 중량부, 용해 보조제 1 내지 30 중량부, Amphiphilic polymer(폴록사머류) 1 내지 30 중량부 및 증류수 39 내지 97.99 중량부를 포함하여 구성되는 나노입자 유용물을 포함하는 것을 특징으로 하는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품.0.01 to 1 part by weight of oleanolic acid, 1 to 30 parts by weight of a solubilizer, 1 to 30 parts by weight of an amphiphilic polymer (Poloxamer) and 39 to 97.99 parts by weight of distilled water Wherein the nanoparticle-containing material has solubilized the poorly soluble oleoanic acid.
  2. 제1항에 있어서,The method according to claim 1,
    상기 올레아노릭산, 용해 보조제는 교반 혼합되어 올레아노릭산 제1혼합물로 만들어지고,The oleoanic acid and the dissolution assistant are stirred and mixed to form a first mixture of oleic acid,
    상기 올레아노릭산 제1혼합물에는 상기 Amphiphilic polymer가 첨가된 이후 가온 상태에서 교반 혼합되어 올레아노릭산 제2혼합물이 만들어지며,The amphiphilic polymer is added to the oleanolic acid first mixture, and then the mixture is stirred at a warmed temperature to prepare a second oleanolic acid mixture.
    상기 올레아노릭산 제2혼합물에는 상기 증류수가 혼합되어 상기 나노입자 유용물이 만들어지는 것을 특징으로 하는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품.Characterized in that the oleanolic acid mixture (2) is mixed with the distilled water to produce the nanoparticle useful product. The anti-aging cosmetic product according to claim 1, wherein the nanoparticulate material is obtained by solubilization of the poorly soluble oleoanic acid.
  3. 제1항에 있어서,The method according to claim 1,
    상기 올레아노릭산, 용해 보조제는 교반 혼합되어 올레아노릭산 제1혼합물로 만들어지고,The oleoanic acid and the dissolution assistant are stirred and mixed to form a first mixture of oleic acid,
    상기 올레아노릭산 제1혼합물에는 상기 Amphiphilic polymer가 첨가된 이후 가온 상태에서 교반 혼합되어 올레아노릭산 제2혼합물이 만들어지는 것을 특징으로 하는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품.Wherein the amphiphilic polymer is added to the oleanolic acid first mixture, and then the mixture is stirred and mixed at a heating temperature to produce a second mixture of oleanolic acid. Aging cosmetics.
  4. 제1항에 있어서,The method according to claim 1,
    상기 용해 보조제(참고_글리콜류 용해제)는,The solubility aids (reference _glycol solubilizers)
    프로필렌글라이콜카프릴레이트( Propylene Glycol Caprylate), 폴리에틸렌글리콜(polyethylene glycol) 중 어느 하나의 것으로 구성되는 것을 특징으로 하는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품.An antioxidant cosmetic comprising nanoparticles useful in solubilizing an insoluble oleanolic acid, characterized in that it is composed of any one of propylene glycol caprylate and polyethylene glycol.
  5. 올레아노릭산(Oleanolic Acid) 0.01내지 1 중량부와 용해 보조제 1 내지 30 중량부를 교반 혼합하여 올레아노릭산 제1혼합물을 만드는 제1단계;0.01 to 1 part by weight of oleanolic acid and 1 to 30 parts by weight of a solubilizing agent are mixed with stirring to prepare a first mixture of oleanolic acid;
    상기 올레아노릭산 제1혼합물에 Amphiphilic polymer(폴록사머류) 1 내지 30 중량부를 추가한 후 가온 상태에서 교반 혼합하여 올레아노릭산 제2혼합물을 만드는 제2단계;A second step of adding 1 to 30 parts by weight of an amphiphilic polymer (Poloxamer) to the oleanolic acid first mixture, followed by stirring and mixing under heating to prepare a second oleanolic acid mixture;
    상기 올레아노릭산 제2혼합물에 증류수 39 내지 97.99 중량부를 추가한 후 교반 혼합하여 나노입자 유용물을 만드는 제3단계 및;A third step of adding 39 to 97.99 parts by weight of distilled water to the oleanolic acid second mixture, followed by stirring and mixing to form a nanoparticle useful product;
    상기 나노입자 유용물을 공지의 화장품에 포함되는 담체 성분과 혼합하여 화장품을 만드는 제4단계;를 포함하여 구성되는 것을 특징으로 하는 난용성 올레아노릭산을 가용화한 나노입자 유용물을 포함하는 항노화 화장품 제조방법.And a fourth step of mixing the nanoparticulate material with the carrier component contained in a known cosmetic product to produce a cosmetic product. The nanoparticle-containing nanoparticle useful in solubilizing the poorly soluble oleoanic acid, Method of manufacturing cosmetics.
PCT/KR2017/015677 2017-12-27 2017-12-28 Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics WO2019132070A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170181368A KR20190079276A (en) 2017-12-27 2017-12-27 Anti-aging cosmetics with nanoparticles-ingredient that solubilized insoluble oligoanionic acid and manufacturing method for anti-aging cosmetics
KR10-2017-0181368 2017-12-27

Publications (1)

Publication Number Publication Date
WO2019132070A1 true WO2019132070A1 (en) 2019-07-04

Family

ID=67067647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/015677 WO2019132070A1 (en) 2017-12-27 2017-12-28 Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics

Country Status (2)

Country Link
KR (1) KR20190079276A (en)
WO (1) WO2019132070A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102396548B1 (en) * 2020-05-28 2022-05-10 한국화학연구원 Nanoparticles that encapsulated with anti-wrinkles, anti-oxidant active ingredient, preparation method thereof and anti-wrinkles cosmetic composition
KR102591099B1 (en) * 2021-03-31 2023-10-18 한스텍주식회사 A manufacturing method of cosmetics that having a moisture and antioxidation function by using natural ingredients
KR102604090B1 (en) * 2022-11-15 2023-11-21 한국콜마주식회사 cosmetic composition for UV protection with stabilized poorly soluble ingredients

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100427777B1 (en) * 2001-09-25 2004-04-28 엔프라니 주식회사 Nanocapsulized ursolic acid and preparing method thereof
KR100715311B1 (en) * 2005-08-24 2007-05-07 한국콜마 주식회사 A cosmeticss to promote the transepidermal absorption and stabilize ursolic acid for anti-wrinkle and its manufacturing method thereof
KR20150093896A (en) * 2014-02-07 2015-08-19 (주)에이씨티 Nanoparticle Containing Poor Soluble Materials, Method for Preparation the Nanoparticle, and Cosmetic Composition Containing the Nanoparticle
JP2016222694A (en) * 2010-11-22 2016-12-28 株式会社アモーレパシフィックAmorepacific Corporation Production method of nano liposome for cosmetics in which oleanolic acid is collected
KR20170003400A (en) * 2015-06-29 2017-01-09 한국화학연구원 Nanoparticles that encapsulated with anti-wrinkles active ingredient, preparation method thereof and anti-wrinkles cosmetic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100891260B1 (en) 2007-05-30 2009-03-30 웅진코웨이주식회사 Triblock copolymer having useful characteristics as cosmetic ingredient and cosmetic composition containing the same
KR101565908B1 (en) 2013-11-28 2015-11-05 한국화학연구원 Pharmaceutical formulation containing micell nanoparticles that encapsulate poorly water soluble drug having good long stability and preparation method thereof
KR101802963B1 (en) 2016-02-26 2017-11-29 농업회사법인 우리엘바이오 주식회사 Cosmetic composition using fermented extracts

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100427777B1 (en) * 2001-09-25 2004-04-28 엔프라니 주식회사 Nanocapsulized ursolic acid and preparing method thereof
KR100715311B1 (en) * 2005-08-24 2007-05-07 한국콜마 주식회사 A cosmeticss to promote the transepidermal absorption and stabilize ursolic acid for anti-wrinkle and its manufacturing method thereof
JP2016222694A (en) * 2010-11-22 2016-12-28 株式会社アモーレパシフィックAmorepacific Corporation Production method of nano liposome for cosmetics in which oleanolic acid is collected
KR20150093896A (en) * 2014-02-07 2015-08-19 (주)에이씨티 Nanoparticle Containing Poor Soluble Materials, Method for Preparation the Nanoparticle, and Cosmetic Composition Containing the Nanoparticle
KR20170003400A (en) * 2015-06-29 2017-01-09 한국화학연구원 Nanoparticles that encapsulated with anti-wrinkles active ingredient, preparation method thereof and anti-wrinkles cosmetic composition

Also Published As

Publication number Publication date
KR20190079276A (en) 2019-07-05

Similar Documents

Publication Publication Date Title
WO2019132070A1 (en) Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics
WO2019235761A1 (en) Fermented emulsifier forming reverse micelles, composition containing same and method for preparing fermented emulsifier
WO2011068333A2 (en) Porous polymethyl methacrylate powder containing functional material for cosmetics, preparation method thereof, and cosmetic composition containing same
KR100949848B1 (en) Nanoemulsion composition comprising Vitamin-C derivative and method for preparing thereof
KR20170076223A (en) Hydrogel Capsule, Preparation Method Thereof and Cosmetic Composition Comprising The Same
WO2021054773A1 (en) Cosmetic composition with multiple emulsion formulation for active ingredient stabilization and skin absorption acceleration
WO2021066381A1 (en) Retinal-containing multilamellar vesicle and cosmetic composition comprising same
CZ298699A3 (en) Preparation for local administration
WO2020071613A1 (en) Makeup base cosmetic composition for skin
CN114259466A (en) Chitosan microemulsion for curcumin transdermal drug delivery and preparation method thereof
EP1414405A1 (en) Invert emulsion containing dhea
WO2015137647A1 (en) Emulsion cosmetic composition without emulsifier
WO2018044035A1 (en) Oil-in-water type cosmetic composition
WO2020085857A1 (en) Transdermal delivery system comprising reverse micelle
WO2021049742A1 (en) Cosmetic composition having excellent percutaneous absorption
JPH0812560A (en) Skin external preparation
WO2021107427A1 (en) Cosmetic composition for skin barrier enhancement or skin bioactive substance absorption promotion
CN112656695A (en) Preparation of retinol nano-emulsion with low irritation and high stability
CN113633614B (en) Efficient antibacterial natural tea tree essential oil nanoemulsion preparation for treating intractable dental ulcer and preparation method and application thereof
WO2018236090A2 (en) Chitosan-pluronic complex and nano-carrier comprising same
WO2020262895A1 (en) Emulsion preconcentrate composition containing protopanaxadiol
WO2013047915A1 (en) Hybrid powder of halloysite nanotube-light scattering nanoparticles, preparation method thereof, and uv screening cosmetic composition containing same as active ingredient
CN114159567B (en) A suspension gel for treating dermatoses
WO2023277479A1 (en) Surface-modified retinoid-impregnated porous silica
JP4001310B2 (en) Lipid complex and composition for external use containing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17936234

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17936234

Country of ref document: EP

Kind code of ref document: A1